
|Articles|March 15, 2004
Studies link tear film osmolarity, ocular surface disease
New information regarding the adverse effects of tear film hyperosmolarity on the ocular surface lends further support to the efficacy of a hypotonic artificial tear product (TheraTears, Advanced Vision Research) in the management of dry eye.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
ONL Therapeutics reports positive phase 1b data for xelafaslatide in geographic atrophy
2
Alcon raises offer in amended deal to acquire STAAR Surgical
3
Neurotrophic keratitis outcomes improve with early, stage-based care
4
Ocular Therapeutix accelerates NDA submission plans for AXPAXLI for wet AMD
5














































.png)


